Oca2 | List of Frontiers open access articles

Original Research

Published on 17 Aug 2022

Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets

in Cancer Immunity and Immunotherapy

Miaoyu Bai
Shanjia Ke
Hongjun Yu
Yanan Xu
Yue Yu
Shounan Lu
Chaoqun Wang
Jingjing Huang
Yong Ma
Wenjie Dai

Frontiers in Immunology

doi 10.3389/fimmu.2022.964891

5,826 views
10 citations

Original Research

Published on 11 Oct 2021

Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism

in Genetics of Common and Rare Diseases

Linya Ma
Jianjian Zhu
Jing Wang
Yazhou Huang
Jibo Zhang
Chao Wang
Yuan Zhou
Dan Peng

Frontiers in Genetics

doi 10.3389/fgene.2021.715437

6,476 views
1 citation

Case Report

Published on 17 Apr 2025

Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2

in Neonatology

Lei Luo
Min Ma
Yanzhang Yang
Hui Zhao

Frontiers in Pediatrics

doi 10.3389/fped.2025.1508198

4,781 views

Original Research

Published on 06 Mar 2023

Identification of novel variations of oculocutaneous albinism type 2 with Prader–Willi syndrome/Angelman syndrome in two Chinese families

in Genetics of Common and Rare Diseases

XiaoFei Chen
ZiShui Fang
Ting Pang
DongZhi Li
Jie Lei
WeiYing Jiang
HongYi Li

Frontiers in Genetics

doi 10.3389/fgene.2023.1135698

3,582 views
2 citations

Brief Research Report

Published on 12 Jul 2022

Identification of 12 OCA Cases in Chinese Population and Two Novel Variants

in Genetics of Common and Rare Diseases

Zilin Zhong
Zheng Zhou
Jianjun Chen
Jun Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.926511

3,534 views
5 citations

Original Research

Published on 24 Apr 2025

High expression of SOX10 is correlated with poor prognosis and immune infiltrates in skin cutaneous melanoma

in Skin Cancer

Xu Sun
Yi-ming Cheng
Meng-wei Sun
Xu-dong Zhang
Xiao-yu Yu
Hai-bo Wang
Yi-fei Wang
Ning Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1444670

3,201 views

Original Research

Published on 28 Apr 2021

Biophysical Compatibility of a Heterotrimeric Tyrosinase-TYRP1-TYRP2 Metalloenzyme Complex

in Experimental Pharmacology and Drug Discovery

Olga Lavinda
Prashiela Manga
Seth J. Orlow
Timothy Cardozo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.602206

4,591 views
12 citations

Articles

Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets

Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism

Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2

Identification of novel variations of oculocutaneous albinism type 2 with Prader–Willi syndrome/Angelman syndrome in two Chinese families

Identification of 12 OCA Cases in Chinese Population and Two Novel Variants

High expression of SOX10 is correlated with poor prognosis and immune infiltrates in skin cutaneous melanoma

Biophysical Compatibility of a Heterotrimeric Tyrosinase-TYRP1-TYRP2 Metalloenzyme Complex